Exact Mass: 644.124

Coenzyme F420-1

C24H29N4O15P (644.1367)

1-O-(E)-Caffeoyl-4,6-(S)-HHDP-beta-D-glucopyranose

C29H24O17 (644.1013)

1-O-(E)-caffeoyl-4,6-(S)-hexahydroxydiphenyl-beta-D-glucopyranose

C29H24O17 (644.1013)

UxpUp

C19H26N4O17P2 (644.0768)

gemin F

C29H24O17 (644.1013)

Luteolinidin-5-(2-O-alpha-D-glucopyranosyl-2-glucose)|Luteolinidin-5-<2-O-alpha-D-glucopyranosyl-2-glucose>

C27H32O18 (644.1589)

quercetin 3-O-(2-O-galloyl-beta-D-glucuronide 6-methyl ester)

C29H24O17 (644.1013)

[8,8-bi-2H-1-benzopyran]-2,2-dione,7-(alpha-D-glucopyranosyloxy)-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]

C33H24O14 (644.1166)

7-hydroxylodesmethoxyrutarensin

C30H28O16 (644.1377)

Metamizole magnesium

C26H32MgN6O8S2 (644.1573)

N-acetyl-8-O-(N-acetyl-a-neuraminyl)-neuraminic acid disodium salt

C22H34N2Na2O17 (644.1653)

Nolotil

C26H32MgN6O8S2 (644.1573)

[(6R)-9-[(2R,3R,4R,5R)-4-hydroxy-5-[[hydroxy-[hydroxy-[[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy]phosphoryl]oxyphosphoryl]oxymethyl]-3-phosphonooxyoxolan-2-yl]-1,2,3,6-tetrahydropurin-6-yl]azanium

C15H29N5O17P3+ (644.0771)

2-Azaniumyl-5-[[3-[[2-[(4-azaniumyl-4-carboxylatobutanoyl)amino]-3-(carboxylatomethylamino)-3-oxopropyl]trisulfanyl]-1-(carboxylatomethylamino)-1-hydroxypropan-2-yl]amino]-5-oxopentanoate

C20H32N6O12S3-2 (644.124)

GDP-N-acetyl-D-glucosamine

C18H26N6O16P2-2 (644.088)

CID 157010209

C20H32N6O12S3 (644.124)

dAp-dAp

C20H26N10O11P2 (644.1258)

A 5-phospho-(3->5)-dinucleotide composed from two dAMP residues.

Thymidine 5-monophosphate dimer

C20H30N4O16P2 (644.1132)

A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of thymidine 5-monophosphate.

alpha-D-Glcp-(1->3)-[L-alpha-D-Hepp-(1->7)]-L-alpha-D-Hepp-4P

C20H37O21P (644.1565)

6-(4,5-dihydroxy-2-{3,5,7-trihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-1-benzopyran-2-yl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C27H32O18 (644.1589)

[(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

(2r,3r)-3-[(10s,11r)-11-formyl-3,4,5,16,17,18-hexahydroxy-8,13-dioxo-9,12-dioxatricyclo[12.4.0.0²,⁷]octadeca-1(18),2(7),3,5,14,16-hexaen-10-yl]-2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

(10s,11r,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

(10s,11r,12r,13s,15s)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

1-o-(e)-caffeoyl-4,6-(s)-hhdp-β-d-glucopy-ranose

C29H24O17 (644.1013)

{"Ingredient_id": "HBIN002900","Ingredient_name": "1-o-(e)-caffeoyl-4,6-(s)-hhdp-\u03b2-d-glucopy-ranose","Alias": "NA","Ingredient_formula": "C29H24O17","Ingredient_Smile": "C1C2C(C(C(C(O2)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2908","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

{3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)

(10s,11s,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H24O17 (644.1013)